the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

S’pore confirms 71 Omicron cases, suspected new cluster at gym

SINGAPORE: Singapore has reported 71 confirmed Omicron cases as at Monday (Dec 20), with 65 being imported cases and six local cases, according to the republic’s Ministry of Health (MOH).

A cluster of three Covid-19 cases linked to a fitness centre has also been detected on Monday, with two cases testing preliminarily positive for the variant and the result for the remaining case is pending.

“All three cases are fully vaccinated and have mild symptoms,” said the ministry in a statement issued late Monday.

MOH said it is ringfencing the cases through contact tracing.

The ministry said the three cases, involving persons aged between 18 and 24, had no recent travel history.

MOH said the epidemiological investigations found that they recently visited the fitness centre between Dec 15 and 17, 2021.

It noted that staff and visitors of the centre who were identified to be close contacts of the cases will be quarantined.

As a precautionary measure, other visitors to the gym between Dec 15 and 17 will be issued Health Risk Warnings (HRW).

“They will also be contacted by MOH for a one-time targeted polymerase chain reaction (PCR) test,” said the ministry.

MOH advised all visitors to the affected premises to monitor their health closely, and minimise social interactions as far as possible for 14 days from their date of visit.

“They are encouraged to see a doctor immediately if they feel unwell,” it said.

As at Dec 20, Singapore’s total Covid-19 caseload stood at 276,105 with 815 fatalities. -Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings